Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV003182930 | SCV003869957 | likely pathogenic | Hereditary cancer-predisposing syndrome | 2022-12-21 | criteria provided, single submitter | clinical testing | The p.C697W variant (also known as c.2091T>G), located in coding exon 13 of the MSH2 gene, results from a T to G substitution at nucleotide position 2091. The cysteine at codon 697 is replaced by tryptophan, an amino acid with highly dissimilar properties. In a massively parallel cell-based functional assay testing susceptibility to a DNA damaging agent, 6-thioguanine (6-TG), this variant was reported to be functionally deleterious (Jia X et al. Am J Hum Genet, 2021 Jan;108:163-175). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Three other alterations at the same codon, p.C697F (c.2090G>T), p.C697R (c.2089T>C), and p.C697Y (c.2090G>A), have been reported in multiple individuals with personal and/or family history consistent with Hereditary Non-Polyposis Colorectal Cancer (HNPCC) or Lynch syndrome, and have been shown to segregate with disease in multiple large families (Wehner M et al. Hum. Mutat., 1997;10:241-4; Wang Q et al. Hum. Genet.; 1999 105:79-85; Isidro G et al. Hum. Mutat., 2000 Jan;15:116; Brieger A et al. Gut, 2002 Nov;51:677-84; Ponz de Leon M et al. Br. J. Cancer, 2004 Feb;90:882-7; Ollila S et al. Gastroenterology, 2006 Nov;131:1408-17; Ollila S et al. Int. J. Oncol., 2006 Jan;28:149-53; Yoon SN et al. Int. J. Cancer, 2008 Mar;122:1077-81; Thodi G et al. BMC Cancer, 2010 Oct;10:544; Pastrello C et al. Genet. Med., 2011 Feb;13:115-24; Langers AMJ et al. Fam Cancer, 2019 07;18:349-352). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for p.C697W is inconclusive. Based on the majority of available evidence to date, this variant is likely to be pathogenic. |
| Myriad Genetics, |
RCV003455778 | SCV004186576 | likely pathogenic | Lynch syndrome 1 | 2023-08-07 | criteria provided, single submitter | clinical testing | This variant is considered likely pathogenic. Functional studies indicate this variant impacts protein function [PMID: 33357406]. This variant is expected to disrupt protein structure [Myriad internal data]. |